Xiao, Changting

Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol

Xiao, C., Dash, S., Morgantini, C., Hegele, R. A., & Lewis, G. F. (2016) · Diabetes

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 212

New insights into the regulation of chylomicron production

Dash, S., Xiao, C., Morgantini, C., & Lewis, G. F. (2015) · Annual Review of Nutrition

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 194

Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans

Xiao, C., Bandsma, R. H. J., Dash, S., Szeto, L., & Lewis, G. F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology

Diabetes Treatment and ManagementLipid metabolism and disorders

Cited by 164

Hypertriglyceridemia in the genomic era: a new paradigm

Lewis, G. F., Xiao, C., & Hegele, R. A. (2015) · Endocrine Reviews

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 152

Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations

Dash, S., Xiao, C., Morgantini, C., Koulajian, K., & Lewis, G. F. (2015) · Diabetes

Pancreatic function and diabetesDiabetes Management and Research

Cited by 108

High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men

Dash, S., Xiao, C., Morgantini, C., Szeto, L., & Lewis, G. F. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology

Sirtuins and Resveratrol in MedicineCholesterol and Lipid Metabolism

Cited by 102

Recent advances in triacylglycerol mobilization by the gut

Xiao, C., Stahel, P., Carreiro, A. L., Buhman, K. K., & Lewis, G. F. (2018) · Trends in Endocrinology & Metabolism

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 77

The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes

Stahel, P., Xiao, C., Hegele, R. A., & Lewis, G. F. (2018) · Canadian Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 75

Glucose and GLP-2 (Glucagon-Like Peptide-2) mobilize intestinal triglyceride by distinct mechanisms

Stahel, P., Xiao, C., Davis, X., Tso, P., & Lewis, G. F. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipid metabolism and disordersLipid metabolism and biosynthesis

Cited by 36

Effects of intranasal insulin on endogenous glucose production in insulin‐resistant men

Xiao, C., Dash, S., Stahel, P., & Lewis, G. F. (2018) · Diabetes, Obesity and Metabolism

Pancreatic function and diabetesDiabetes Management and Research

Cited by 19